Omeros Stock Performance
| OMER Stock | USD 8.42 0.56 7.12% |
On a scale of 0 to 100, Omeros holds a performance score of 4. The company holds a Beta of 3.19, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Omeros will likely underperform. Please check Omeros' maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to make a quick decision on whether Omeros' historical price patterns will revert.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Omeros are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak technical and fundamental indicators, Omeros reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 7.12 | Five Day Return 12.27 | Year To Date Return (14.43) | Ten Year Return (65.11) | All Time Return (3.55) |
Last Split Factor 1:1.96 | Last Split Date 2009-10-02 |
1 | Omeros Reports Narsoplimab TA-TMA Trial Success Stock Surges | 12/19/2024 |
2 | retail investors who own 52 percent along with institutions invested in Omeros Corporation saw increase in their holdings value last week | 12/23/2024 |
3 | Omeros Receives Buy Rating from D. Boral Capital - MarketBeat | 01/17/2025 |
4 | Iovance Biotherapeutics Shares Fell Today Whats Going On | 02/10/2025 |
5 | Clinical Developments Push Omeros Corporation Into the Spotlight | 02/11/2025 |
6 | Acquisition by Cable Thomas J. of 15000 shares of Omeros at 3.91 subject to Rule 16b-3 | 02/14/2025 |
7 | Omeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMA | 02/20/2025 |
8 | Acquisition by Michael Jacobsen of 75000 shares of Omeros at 14.99 subject to Rule 16b-3 | 02/28/2025 |
9 | DRI Healthcare Trust Reports Fourth Quarter and Annual 2024 Results | 03/03/2025 |
10 | Omeros Corporation Receives Commitment of Over 4 Million from NIDA for Further Development of the Companys OMS527 Program to Treat Cocaine Use Disorder | 03/13/2025 |
| Begin Period Cash Flow | 11 M |
Omeros |
Omeros Relative Risk vs. Return Landscape
If you would invest 759.00 in Omeros on December 16, 2024 and sell it today you would earn a total of 83.00 from holding Omeros or generate 10.94% return on investment over 90 days. Omeros is currently generating 0.3974% in daily expected returns and assumes 7.086% risk (volatility on return distribution) over the 90 days horizon. In different words, 63% of stocks are less volatile than Omeros, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Omeros Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Omeros' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Omeros, and traders can use it to determine the average amount a Omeros' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0561
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | OMER | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.09 actual daily | 63 63% of assets are less volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Omeros is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Omeros by adding it to a well-diversified portfolio.
Omeros Fundamentals Growth
Omeros Stock prices reflect investors' perceptions of the future prospects and financial health of Omeros, and Omeros fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Omeros Stock performance.
| Return On Equity | -5.76 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 541.8 M | ||||
| Shares Outstanding | 57.95 M | ||||
| Price To Earning | 0.73 X | ||||
| Price To Book | 8.44 X | ||||
| Price To Sales | 4.93 X | ||||
| Gross Profit | (69.78 M) | ||||
| EBITDA | (163.61 M) | ||||
| Net Income | (117.81 M) | ||||
| Cash And Equivalents | 122.56 M | ||||
| Cash Per Share | 1.95 X | ||||
| Total Debt | 361.58 M | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | (2.66) X | ||||
| Cash Flow From Operations | 74.73 M | ||||
| Earnings Per Share | (3.14) X | ||||
| Market Capitalization | 487.94 M | ||||
| Total Asset | 378.27 M | ||||
| Retained Earnings | (753.53 M) | ||||
| Working Capital | 306.85 M | ||||
| Current Asset | 37.15 M | ||||
| Current Liabilities | 16.25 M | ||||
About Omeros Performance
Assessing Omeros' fundamental ratios provides investors with valuable insights into Omeros' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Omeros is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.58) | (0.61) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | 4.24 | 4.46 |
Things to note about Omeros performance evaluation
Checking the ongoing alerts about Omeros for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Omeros help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Omeros had very high historical volatility over the last 90 days | |
| Omeros has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (117.81 M) with loss before overhead, payroll, taxes, and interest of (69.78 M). | |
| Omeros has a poor financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: Omeros Corporation Receives Commitment of Over 4 Million from NIDA for Further Development of the Companys OMS527 Program to Treat Cocaine Use Disorder |
- Analyzing Omeros' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Omeros' stock is overvalued or undervalued compared to its peers.
- Examining Omeros' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Omeros' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Omeros' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Omeros' stock. These opinions can provide insight into Omeros' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Omeros Stock Analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.